The role of hepatokines in metabolism

Stefan, Norbert, Häring, Hans-Ulrich·2013·Nature Reviews Endocrinology
DOI 10.1038/nrendo.2012.258

Cited by (500)

Items 201–300 of 500

  1. Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice
    Go Sugahara, Yuji Ishida, Jeffrey C. Sun, Chise Tateno, Takeshi Saito · 2020 · Seminars in Liver Disease
  2. Preventing Diabetes: Early Versus Late Preventive Interventions
    Jaakko O. Tuomilehto, Peter E. H. Schwarz · 2016 · Diabetes Care
  3. Birthweight, mediating biomarkers and the development of type 2 diabetes later in life: a prospective study of multi-ethnic women
    Yan Song, Yen‐Tsung Huang, Yiqing Song, Andrea Lynn Hevener, Kelli K. Ryckman, Lihong Qi, Erin S. LeBlanc, Rasa Kazlauskaite, Kathleen M. Brennan, Simin Liu · 2015 · Diabetologia
  4. Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects
    ZHEN KUN YANG, Hongmei Zhang, Yixin Niu, Weiwei Zhang, Lingfei Zhu, Xiaoyong Li, Shuai Lü, Jian‐Gao Fan, Xiaoying Li, Guang Ning et al. · 2016 · Scientific Reports
  5. Fetuin-A is also an adipokine
    Ishwarlal Jialal, Roma Pahwa · 2019 · Lipids in Health and Disease
  6. Plasma fetuin-A triggers inflammatory changes in macrophages and adipocytes by acting as an adaptor protein between NEFA and TLR-4
    Satinath Mukhopadhyay, Samir Bhattacharya · 2016 · Diabetologia
  7. MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial
    Line Velling Magnussen, Poul Erik Andersen, A Diaz, Jelena Nesovic Ostojic, Kurt Højlund, DAVID MICHAEL HOUGAARD, Anders Nymark Christensen, Torben Leo Nielsen, Marianne Andersen · 2017 · European Journal of Endocrinology
  8. cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation.
    Andras Franko, M. Kovářová, S. Feil, R. Feil, R. Wagner, M. Heni, A. Königsrainer, M. Ruoß, A. Nussler, C. Weigert et al. · 2018 · Metabolism: Clinical and Experimental
  9. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study
    Simone Jacobs, Susanne Jäger, Eugène Jansen, Andreas Peter, Norbert Stefan, Heiner Boeing, Matthias Bernd Schulze, Janine Kröger · 2015 · PLoS ONE
  10. Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease
    Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Atsushi Umemura, Taichiro Nishikawa et al. · 2017 · Hepatology Research
  11. Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity
    Stefan Z. Lutz, Andreas Peter, Fausto E Machicao, Apostolia Lamprinou, Jürgen Machann, Fritz Schick, Ingmar Königsrainer, Alfred Königsrainer, Andreas Fritsche, Harald Staiger et al. · 2016 · The Journal of Clinical Endocrinology & Metabolism
  12. An extended fatty liver index to predict non-alcoholic fatty liver disease
    Kοnstantinos Kantartzis, Ingo Rettig, Harald Staiger, Jürgen Machann, Fritz Schick, Ludger Scheja, Amalia Gastaldelli, Elisabetta Bugianesi, Andreas Peter, Matthias Bernd Schulze et al. · 2017 · Diabetes & Metabolism
  13. Effect of circulating glucagon and free fatty acids on hepatic FGF21 production in dairy cows
    L.S. Caixeta, Sarah L. Giesy, Christopher S. Krumm, James W. Perfield, Anthony M. Butterfield, K.M. Schoenberg, Donald C. Beitz, Yves R. Boisclair · 2017 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  14. Serum fetuin‐B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross‐sectional study
    Dongmei Wang, Yijie Liu, Suhuan Liu, Lin Lin, Changqin Liu, Xiulin Shi, Zheng Chen, Mingzhu Lin, Shuyu Yang, Zhibin Li et al. · 2017 · Journal of Diabetes
  15. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease
    Shousheng Liu, Jianhan Xiao, Zhenzhen Zhao, Mengke Wang, Yifen Wang, Yongning Xin · 2020 · Journal of Clinical and Translational Hepatology
  16. Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice
    Stanley M. H. Chan, Xiao‐Yi Zeng, Ruo‐Qiong Sun, Eunjung Jo, Xiu Zhou, Hao Wang, Songpei Li, Aimin Xu, Matthew J. Watt, Ji‐Ming Ye · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  17. Causal relationship between body mass index and fetuin‐ A level in the asian population: a bidirectional mendelian randomization study
    Ammarin Thakkinstian, La‐or Chailurkit, Daruneewan Warodomwichit, Wipa Ratanachaiwong, Sukit Yamwong, Suwannee Chanprasertyothin, John Attia, Piyamitr Sritara, Boonsong Ongphiphadhanakul · 2013 · Clinical Endocrinology
  18. Bridging data and drug development: Machine learning approaches for next-generation ADMET prediction
    Ning Fan, Jing Chen, Jinghui Wang, Zhe‐Sheng Chen, Yinfeng Yang · 2025 · Drug Discovery Today
  19. Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
    P. Simons, O. Valkenburg, M. V. D. van de Waarenburg, M. V. van Greevenbroek, M. Kooi, J. Jansen, C. Schalkwijk, C. Stehouwer, M. Brouwers · 2022 · Diabetologia
  20. Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
    Christian von Loeffelholz, P. Horn, Andreas L. Birkenfeld, Ralf Alexander Claus, Uta Barbara Metzing, Stephanie Döcke, Gerhard Jahreis, Regine Heller, S Hoppe, Martin Stockmann et al. · 2016 · Journal of Investigative Surgery
  21. Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
    Zhengsen Cui, Rong Xuan, Yunmei Yang · 2017 · Oncotarget
  22. The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis
    Mouchiroud, Mathilde, Camiré, Étienne, Aldow, Manal, Caron, Alexandre, Jubinville, Éric, Turcotte, Laurie, Kaci, Inés, Beaulieu, Marie-Josée, Roy, Christian, Labbé, Sébastien M. et al. · 2019 · Molecular Metabolism
  23. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
    Mariam M. Ali, Sanober Parveen, Vanessa R. Williams, Robert F. Dons, Gabriel Ikponmosa Uwaifo · 2024 · Journal of Clinical & Translational Endocrinology
  24. Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions
    Sara Parrettini, Massimiliano Cavallo, Francesco Gaggia, Riccardo Calafiore, Giovanni Luca · 2020 · Protein and Peptide Letters
  25. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance
    Oliver Stöhr, Rongya Tao, Ji Miao, Kyle D. Copps, Morris F. White · 2021 · Cell Reports
  26. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
    Anna Hadjihambi · 2021 · Analytical Biochemistry
  27. Hepatic p38 Activation Modulates Systemic Metabolism Through FGF21-Mediated Interorgan Communication
    Wei Liu, Chao Sun, Ying Yan, Hongchao Cao, Zhoumin Niu, Siyi Shen, Shengnan Liu, Yuting Wu, Li Yan, Lijian Hui et al. · 2021 · Diabetes
  28. Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective
    Yao Zhang, Yibing Wang, Junli Liu · 2022 · Genes & Diseases
  29. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure
    Quan Pan, Weiqi Ai, Yunmei Chen, Da Mi Kim, Zheng Shen, Wanbao Yang, Wen Jiang, Yuxiang Sun, Stephen H Safe, Shaodong Guo · 2023 · Diabetes
  30. - Invited Review - Physiological Roles of Adipokines, Hepatokines, and Myokines in Ruminants
    Sanggun Roh, Yutaka Suzuki, Takafumi Gotoh, Ryuichi Tatsumi, Kazuo Katoh · 2015 · Asian-Australasian Journal of Animal Sciences
  31. Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters
    Zhen Zhang, Huixian Zeng, Jianghong Lin, Yinghui Hu, Rui Yang, Jia Sun, Rongping Chen, Hong Chen · 2018 · Medicine
  32. Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
    Marta Flisiak‐Jackiewicz, Anna Bobrus‐Chociej, Natalia Wasilewska, Eugeniusz Tarasów, Małgorzata Wojtkowska, Dariusz Marek Lebensztejn · 2019 · Advances in Medical Sciences
  33. Leukocyte cell‐derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT‐1 pathway in mice
    Jinghua Wang, Yishu Chen, Ran Pan, Chao Wu, Shenghui Chen, Lan Li, Youming Li, Chaohui Yu, Zhuo‐Xian Meng, Chengfu Xu · 2021 · Liver International
  34. Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine
    Yaxing Zhang, Xian-Ming Fang · 2021 · Evidence-based Complementary and Alternative Medicine
  35. Impact of hepatic HSP72 on insulin signaling
    Sayaka Kitano, Tatsuya Kondo, Rina Matsuyama, Kaoru Ono, Rieko Goto, Yuki Takaki, Satoko Hanatani, Masaji Sakaguchi, Motoyuki Igata, Junji Kawashima et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
  36. Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4
    Jinxin Liu, Chenzhipeng Nie, Lamei Xue, Ying Yan, Shengnan Liu, Juan Sun, Mingcong Fan, Haifeng Qian, Hao Ying, Li Wang et al. · 2021 · Theranostics
  37. Organokines and Exosomes: Integrators of Adipose Tissue Macrophage Polarization and Recruitment in Obesity
    Yuan Yuan Wang, Yadi Wang, Xiao-Yan Qi, Zhe‐Zhen Liao, Yun-Ni Mai, Xinhua Xiao · 2022 · Frontiers in Endocrinology
  38. The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone
    Changyan Zi, Die Wang, Yongxiang Gao, Lisha He · 2023 · Frontiers in Immunology
  39. Multiphasic Regulation of Systemic and Peripheral Organ Metabolic Responses to Cardiac Hypertrophy
    Chong Wee Liew, Shanshan Xu, Xuerong Wang, Maximilian A. McCann, Hyerim Whang Kong, Andrew N. Carley, Jingbo Pang, Giamila Fantuzzi, J. Michael O’Donnell, E. Douglas Lewandowski · 2017 · Circulation Heart Failure
  40. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice
    Stefanie Y. Tan, Xia Lei, Hannah C. Little, Susana Rodriguez, Dylan C. Sarver, Xi Cao, Guang William Wong · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  41. Potential Mechanisms for How Long-Term Physical Activity May Reduce Insulin Resistance
    Sindre Lee-Ødegård, Thomas Olsén, Frode Norheim, Christian Andre Drevon, Kåre I. Birkeland · 2022 · Metabolites
  42. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
    Sugan Panneerselvam, Cornelia M. Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese · 2023 · Cell Adhesion & Migration
  43. The Pan-liver Network Theory
    Yaxing Zhang, Xian-Ming Fang · 2023 · The Chinese Journal of Physiology
  44. Effects of Turmeric on Homocysteine and Fetuin-A in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Placebo-Controlled Study
    Aida Ghaffari, Maryam Rafraf, Roya Navekar, Bita Sepehri, Mohammad Asghari Jafarabadi, Seyyed-Mostafa Ghavami, Nahid Manafi · 2017 · Iranian Red Crescent Medical Journal
  45. Tsukushi and TSKU genotype in obesity and related metabolic disorders
    Y Li, L. Jin, Jing Ying Yan, Yunhong Huang, H Zhang, R Zhang, Cheng Hu · 2021 · Journal of Endocrinological Investigation
  46. Fetuin-A – Alpha2-Heremans-Schmid Glycoprotein: From Structure to a Novel Marker of Chronic Diseases Part 1. Fetuin-A as a Calcium Chaperone and Inflammatory Marker
    Regina Komsa‐Penkova, Georgi M. Golemanov, Zdravka V. Radionova, Pencho Tonchev, Sergej D. Iliev, Veselin P. Penkov · 2017 · Journal of Biomedical and Clinical Research
  47. Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease
    Ebba Beller, Roberto Lorbeer, Daniel Keeser, Franziska Schoeppe, Sabine Sellner, Holger Hetterich, Fabian Bamberg, Christopher L. Schlett, Annette Peters, Birgit Betina Ertl-Wagner et al. · 2019 · European Radiology
  48. Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
    Tim Hollstein, Paolo Piaggi · 2020 · Current Obesity Reports
  49. Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome
    Mariana Boulos, Rabia S. Mousa, Nizar Jeries, Elias Simaan, Klode Alam, Bulus Bulus, Nimer Assy · 2025 · International Journal of Molecular Sciences
  50. The endocrine role of hepatokines: implications for human health and disease
    Pedro Iglesias · 2025 · Frontiers in Endocrinology
  51. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease
    Thomas Ebert, Nicolas Linder, Alexander Schaudinn, Harald Busse, Joachim Berger, Ralf Lichtinghagen, Volker Keim, Johannes Wiegand, Thomas Karlas · 2017 · Endocrine
  52. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiency
    Teresa Vanessa Fiorentino, Sofia Miceli, Elena Succurro, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti · 2020 · Journal of Internal Medicine
  53. Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis
    Maria T. Vamvini, Ole‐Petter R. Hamnvik, Ayse Sahin-Efe, Anna Gavrieli, Fadime Dincer, Olivia M. Farr, Christos Socrates Mantzoros · 2016 · The Journal of Clinical Endocrinology & Metabolism
  54. Contribution of Liver Fat to Weight Loss–Induced Changes in Serum Hepatokines: A Randomized Controlled Trial
    Telgenkamp, Ine, Kusters, Yvo H A M, Schalkwijk, Casper G, Houben, Alfons J H M, Kooi, M Eline, Lindeboom, Lucas, Bons, Judith A P, Schaper, Nicolaas C, Joris, Peter J, Plat, Jogchum et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
  55. Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
    Yun Kyung Cho, Myungjin Kim, Ye‐Jee Kim, Chang Hee Jung, Woo Je Lee, Joong‐Yeol Park · 2023 · Frontiers in Cardiovascular Medicine
  56. Genetic determination of body fat distribution and the attributive influence on metabolism
    Ellen Fehlert, Robert J. Wagner, Caroline Ketterer, Anja Böhm, Jürgen Machann, Louise Fritsche, Fausto E Machicao, Fritz Schick, Harald Staiger, Norbert Stefan et al. · 2017 · Obesity
  57. Longitudinal changes in sex hormone binding globulin (SHBG) and risk of incident diabetes: the study of women’s health across the nation (SWAN)
    Hedderson, Monique M., Capra, Angela, Lee, Catherine, Habel, Laurel A., Lee, Jennifer, Gold, Ellen B., Badon, Sylvia E., Mitro, Susanna D., El Khoudary, Samar R. · 2024 · Diabetes Care
  58. Longitudinal associations between cardiovascular biomarkers and metabolic syndrome during puberty: the PUBMEP study
    Esther M. González‐Gil, Augusto Anguita‐Ruiz, Anton Kalén, Carmela de Lamas, Azahara I. Rupérez, Rocío Vázquez‐Cobela, Katherine Flores‐Rojas, Ángel Gil, Mercedes Gil‐Campos, Gloria Bueno et al. · 2022 · European Journal of Pediatrics
  59. Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses
    Jianli He, Yalan Chen, Huihua Ding, Jin‐An Zhou, Zhengcao Xing, Xinyu Yang, Qiuju Fan, Yong Zuo, Tianshi Wang, Jinke Cheng · 2024 · Journal of Clinical Investigation
  60. Selenoprotein P is not elevated in gestational diabetes mellitus
    Alev Eroğlu Altınova, Özlem Turhan İyidir, Çiğdem Özkan, Damla Ors, Merve Öztürk, Özlem Gülbahar, Nuray Bozkurt, Füsun Baloş Törüner, Müjde Aktürk, Nuri Çakır et al. · 2015 · Gynecological Endocrinology
  61. New emerging roles of the novel hepatokine SERPINB1 in type 2 diabetes mellitus: Crosstalk with β-cell dysfunction and dyslipidemia
    Mohamed Mostafa Kamal, Aya Adel, Ghada H. Sayed, Shadia Hassan Ragab, Dina Hamada Kassem · 2020 · Translational research
  62. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity
    Rinke Stienstra, Norbert Stefan · 2013 · Diabetologia
  63. Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease
    Theodor Baars, Robert K. H. Gieseler, Polykarpos Patsalis, Ali E. Canbay · 2022 · Metabolism
  64. Steatotic hepatocyte‐derived extracellular vesicles promote β‐cell apoptosis and diabetes via microRNA ‐126a‐3p
    Qi Chen, Fang‐jie Jiang, Xin Gao, Xiao‐Ying Li, Pu Xia · 2023 · Liver International
  65. CIRCULATING IGFBP-2 LEVELS ARE INCREMENTALLY LINKED TO CORRELATES OF THE METABOLIC SYNDROME AND INDEPENDENTLY ASSOCIATED WITH VLDL TRIGLYCERIDES
    S. Carter, Zhuoying Li, Natalie Alméras, Angelo Tremblay, Jean Bergeron, Paul Poirier, Yves Deshaies, Jean‐Philippe Després, Frédéric Picard · 2014 · Canadian Journal of Cardiology
  66. Pathophysiological significance of hepatokine overproduction in type 2 diabetes
    Hirofumi Misu · 2018 · Diabetology International
  67. Study rationale and protocol of the BARICO study: a longitudinal, prospective, observational study to evaluate the effects of weight loss on brain function and structure after bariatric surgery
    Debby Vreeken, Maximilian Wiesmann, Laura N. Deden, Ilse A.C. Arnoldussen, Esther Aarts, Roy P. C. Kessels, Robert Kleemann, Eric J. Hazebroek, Edo Oscar Aarts, Amanda J. Kiliaan · 2019 · BMJ Open
  68. Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
    Jing Cheng, Xing Su, Lei Qiao, Chungang Zhai, Wenqiang Chen · 2018 · Bioscience Reports
  69. Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults
    Zhibin Li, Chunmei He, Yongwen Liu, Dongmei Wang, Mingzhu Lin, Changqin Liu, Xiulin Shi, Zheng Chen, Xuejun Li, Shuyu Yang et al. · 2019 · Journal of Atherosclerosis and Thrombosis
  70. Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
    Aikaterini Giannouli, Charikleia Stefanaki, Christos Kouskoutis, Marianna Konidari, Iliana Mani, Konstantina Konidari, Sophia L. Markantonis, Aimilia Mantzou, Spyridon P. Dourakis, Efthymios Deligeoroglou et al. · 2023 · Journal of Clinical Medicine
  71. HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis
    Yang Yang, Xian Liu, Hui Chen, Pengjun Wang, Songhui Yao, Bin Zhou, Ronghua Yin, Chang‐Yan Li, Chutse Wu, Xiaoming Yang et al. · 2022 · FEBS Journal
  72. Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
    Gabriella Garruti, Jacek Baj, Angelo Cignarelli, Sebastio Perrini, Francesco Giorgino · 2023 · Frontiers in Endocrinology
  73. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study
    Ji Young Kim, Choae Lee, Minsuk Oh, Jee-Aee Im, Ji‐Won Lee, Sang Hui Chu, Hyangkyu Lee, Justin Y. Jeon · 2016 · Clinica Chimica Acta
  74. Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
    Ahmed Kamel Elsayed, Selvaraj Vimalraj, Manjula Nandakumar, Essam Mohamed Abdelalim · 2021 · World Journal of Stem Cells
  75. Decreases in hepatokine Fetuin-A levels are associated with hepatic hypoperfusion and predict cardiac outcomes in patients with heart failure
    Yusuke Tomita, Tomofumi Misaka, Akiomi Yoshihisa, Yasuhiro Ichijo, Shinji Ishibashi, Mitsuko Matsuda, Yukio Yamadera, Himika Ohara, Yukiko Sugawara, Yu Hotsuki et al. · 2022 · Clinical Research in Cardiology
  76. Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study
    Sahar Abd El-mohsen Ali, Walaa M.H. Nassif, Dalia H. Abdelaziz · 2016 · Clinics and Research in Hepatology and Gastroenterology
  77. The Role of Kupffer Cells as Mediators of Adipose Tissue Lipolysis
    Weide Ma, Dianyuan Zhao, Fuchu He, Li Tang · 2019 · The Journal of Immunology
  78. Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
    Shandiz Morega, Bogdan Cătălin, Cristiana Eugenia Simionescu, Konstantinos G. Sapalidis, Ion Rogoveanu · 2021 · Brain Sciences
  79. White adipose tissue: Distribution, molecular insights of impaired expandability, and its implication in fatty liver disease
    Griselda Mericia Rabadán-Chávez, Rocío Isabel Díaz de la Garza, Daniel A. Jacobo‐Velázquez · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  80. UV-activated “blue bulbs” for photodecomposition and adsorption of bilirubin: Strategic nanoarchitectonics to remove protein-bound toxins
    Yilin Wang, Ran Wei, Xijing Yang, Jiahao Liang, Xianda Liu, Shengjun Cheng, Shifan Chen, Ziyue Ling, Yujie Xiao, Yuanting Xu et al. · 2024 · Materials Today
  81. Activin E enhances insulin sensitivity and thermogenesis by activating brown/beige adipocytes
    Kazunari Sekiyama, Yuuki Ushiro, Akira Kurisaki, Masayuki Funaba, Osamu Hashimoto · 2019 · Journal of Veterinary Medical Science
  82. Transcriptomic comparison of liver tissue between Anqing six-end-white pigs and Yorkshire pigs based on RNA sequencing
    Yuanlang Wang, Wei Zhang, Xudong Wu, Chaodong Wu, Qian Li, Li Wang, Xiaodong Zhang, Min Yang, Dengtao Li, Jian Ding et al. · 2020 · Genome
  83. Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease
    Hao Li, Zhengzhen Wang, Yan Wang, Juan Wang, Zhipeng Zeng · 2020 · Medical Science Monitor
  84. Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
    Anna M. Baran, Julia Nowowiejska, Julita Anna Krahel, Tomasz Waldemar Kaminski, Magdalena Maciaszek, Iwona Flisiak · 2020 · International Journal of Molecular Sciences
  85. Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
    Kiera Ward, Edwin R. Mulder, Petra Frings‐Meuthen, Donal J. O’Gorman, Diane Cooper · 2020 · Frontiers in Physiology
  86. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk
    Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian, Michelangelo Foti · 2022 · International Journal of Molecular Sciences
  87. Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone
    Hui Zhu, Ningjian Wang, Bing Han, Li Qin, Yi Chen, Chunfang Zhu, Yingchao Chen, Fangzhen Xia, Zhen Cang, Meng Lu et al. · 2016 · PLoS ONE
  88. To be or not to be cell autonomous? Autophagy says both
    Nina Fenouille, Anna Chiara Nascimbeni, Joëlle Botti, Nicolas Dupont, Étienne Morel, Patrice Codogno · 2017 · Essays in Biochemistry
  89. Periaortic Adipose Tissue Compared With Peribrachial Adipose Tissue Mass as Markers and Possible Modulators of Cardiometabolic Risk
    Elko Randrianarisoa, Norbert Stefan, Andreas Fritsche, Nadja Vera Reis-Damaschke, Anja Hieronimus, Bernd M. Balletshofer, Jürgen Machann, Dorothea I. Siegel-Axel, Hans‐Ulrich Häring, Kilian Rittig · 2018 · Angiology
  90. Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome
    Qiuyu Wang, Peng Zhang, Işın Çakır, Lin Mi, Roger D. Cone, Jiandie D. Lin · 2021 · Diabetes
  91. Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review
    A. Ahmadi Hekmatikar, Andres Nelson, Aaron C. Petersen · 2023 · BMC Cancer
  92. Characterization of FGF21 Sites of Production and Signaling in Mice
    Andrew I. Sullivan, Sharon O. Jensen-Cody, Kristin E. Claflin, Kai Vorhies, Kyle H. Flippo, Matthew J. Potthoff · 2024 · Endocrinology
  93. Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials
    Michel M. Joosten, Ilse C. Schrieks, H. Hendriks · 2014 · Diabetology & Metabolic Syndrome
  94. The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise
    Ji Ye Lim, Eunju Kim · 2023 · Metabolites
  95. Association of Human Fetuin-A rs4917 Polymorphism with Obesity in 2 Cohorts
    György Temesszentandrási, Krisztián Vörös, Zoltán Böröcz, Edit Kaszás, Zoltán Prohászka, András Falus, Károly Cseh, László Kalabay · 2015 · Journal of Investigative Medicine
  96. Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents
    Kyung Hee Yi, Jin Soon Hwang, Se Won Lim, Jun Ah Lee, Dong Ho Kim, Jung Sub Lim · 2016 · Journal of Pediatric Endocrinology and Metabolism
  97. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice
    Sylvie Casteras, Aya Abdul-Wahed, Maud Soty, Fanny Vulin, Hervé Guillou, Maria B. Campaña, Hervé Le Stunff, Luciano Pirola, Fabienne Rajas, Gilles Mithieux et al. · 2016 · Diabetologia
  98. Central metabolic-sensing remotely controls nutrient –sensitive endocrine response in Drosophila via Sir2/Sirt1-upd2-IIS axis
    Kushal K. Banerjee, Rujuta Deshpande, Pranavi Koppula, Champakali Ayyub, Ullas Kolthur‐Seetharam · 2017 · Journal of Experimental Biology
  99. Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study*
    Piya Chaemsaithong, Roberto J. Romero, Adi Laurentiu Tarca, Steven J. Korzeniewski, Alyse G. Schwartz, Jezid Miranda, Ahmed I. Ahmed, Zhong Dong, Sonia S. Hassan, Lami Yeo et al. · 2014 · The Journal of Maternal-Fetal & Neonatal Medicine
  100. Mechanisms Explaining the Relationship Between Metabolically Healthy Obesity and Cardiovascular Risk
    Norbert Stefan, Andreas Fritsche, Hans‐Ulrich Häring · 2014 · Journal of the American College of Cardiology